| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
1 company
Abg Management Ltd is a 10% Owner at SRNE. Recent filings cover 3 purchases and 14 sales. Those positions are worth an estimated $5.0M at current prices.
Abg Management Ltd's largest disclosed position is in SRNE as 10% Owner, worth about $5.0M. Net of sales, the recent Form 4 record there shows accumulation of 1,708,799 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 13, 2018 | SRNE Sorrento Therapeutics, Inc. | 10% Owner | Sell | 297,568 | $5.02 | $1,492,723.49 | -22.7% | |
| Feb 7, 2018 | SRNE Sorrento Therapeutics, Inc. | 10% Owner | Sell | 662,912 | $6.85 | $4,542,233.94 | -33.3% | |
| Feb 5, 2018 | SRNE Sorrento Therapeutics, Inc. | 10% Owner | Sell | 70,721 | $8.00 | $566,036.74 | -4.8% | |
| Jan 30, 2018 | SRNE Sorrento Therapeutics, Inc. | 10% Owner | Sell | 310,000 | $7.64 | $2,368,864.24 | -17.9% | |
| Apr 19, 2017 | SRNE Sorrento Therapeutics, Inc. | 10% Owner | Buy | 550,000 | $2.00 | $1,100,000.00 | +38.2% | |
| Apr 13, 2017 | SRNE Sorrento Therapeutics, Inc. | 10% Owner | Buy | 2,500,000 | $2.00 | $5,000,000.00 | -250.0% |